Adenosine vs AF Termination for Paroxysmal AF Ablation

• Register: ClinicalTrials.gov
• Last refreshed on: 19 February 2015
• Main ID: NCT02238392
• Date of registration: 09/09/2014
• Prospective Registration: No
• Primary sponsor: Johannes Gutenberg University Mainz
• Public title: Adenosine vs AF Termination for Paroxysmal AF Ablation
• Scientific title: Arrhythmia Inducibility Versus Elimination of Dormant PV Conduction as a Procedural Endpoint of Catheter Ablation for Paroxysmal Atrial Fibrillation: a Prospective Randomized Trial
• Date of first enrolment: January 2012
• Target sample size: 150
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT02238392
• Study type: Interventional
• Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
• Phase: N/A

Countries of recruitment

Germany

Contacts

• Name: Thomas Rostock, MD
• Affiliation: University Hospital Mainz, Dept. of Cardiology

Key inclusion & exclusion criteria

Inclusion Criteria:

- patients with paroxysmal AF

- de-novo AF ablation

- age > 18 years

Exclusion Criteria:

- persistent AF

- previous cardioversion



Age minimum: 18 Years
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Paroxysmal Atrial Fibrillation

Intervention(s)

Procedure: Termination of AF

Procedure: Adenosine test

Primary Outcome(s)

Arrhythmia-free survival [Time Frame: 1 year]

Secondary Outcome(s)

Recurrence if PV conduction after ablation in PVs with abolished dormant conduction [Time Frame: 1 year]

Secondary ID(s)

1/2014

Source(s) of Monetary Support

Please refer to primary and secondary sponsors